Introduction {#S1}
============

Sodium ion (Na^+^) is an essential mineral to maintain extracellular fluid (ECF)/blood volume. Depletion of sodium leads to an increase in sodium appetite, a strong motivation for animals to consume otherwise aversive concentrations of sodium^[@R1]^. Recently, several studies identified neural circuits and molecular mechanisms underlying the promotion of sodium appetite^[@R2],[@R3],[@R4]^. However, sodium appetite is not strongly manifested in normal conditions, suggesting that it may be suppressed. Indeed, high concentrations of sodium are typically aversive in the euvolemic state, which is in part mediated by a peripheral mechanism^[@R5]^. Yet, a central mechanism underlying suppression of sodium appetite is currently unknown. Previous pharmacological studies suggested that the lateral parabrachial nucleus (LPBN) plays a role in suppressing sodium appetite^[@R6],[@R7]^. However, lesions to the LPBN failed to increase sodium appetite^[@R8],[@R9]^, which otherwise seems to suggest that the LPBN is not involved in suppressing sodium appetite during euvolemic states. This discrepancy may in part be due to the heterogeneous nature of the LPBN, as this nucleus has been shown to also contain a population of neurons that putatively promote sodium appetite^[@R10]^. Thus, the identity of LPBN neuronal subpopulations that suppress sodium appetite remains to be revealed.

Brain serotonin receptors were proposed to control sodium appetite, but the results were not consistent between studies, possibly due to the use of different drugs^[@R11],[@R12]^. Likewise, infusions of drugs that affect serotonergic signalling within the LPBN have been shown to have mixed effects on sodium intake^[@R13],[@R14]^. These pharmacological studies suggest that serotonergic mechanisms within the LPBN contribute to alter sodium appetite. However, they lack cellular and temporal specificity, which limits the interpretations of these results. Importantly, no information is currently available regarding the physiological role of specific types of serotonin receptors expressed by LPBN neurons in regulating sodium balance.

In order to resolve the issues raised by past studies, we genetically segregated a population of LPBN neurons that express serotonin 2C receptors (Htr2c) (LPBN^Htr2c^ neurons), and investigated their potential role and the relevant circuitry in mediating the suppression of sodium appetite. Furthermore, we explored the physiological role of this neuronal population in the control of sodium appetite.

Results {#S2}
=======

LPBN^Htr2c^ neurons are regulated by bodily sodium content {#S3}
----------------------------------------------------------

To examine whether LPBN^Htr2c^ neurons respond to high concentrations of sodium, we performed fluorescent *in situ* hybridisation for *Fos*. Mice were gastrically loaded via oral gavage with either saline (154 mM NaCl) or hypertonic saline (1.5 M NaCl) and then sacrificed 25 minutes later. Consistent with previous reports^[@R15],[@R16]^, we saw a robust increase in *Fos* expression throughout the LPBN ([Extended Data Fig. 1](#F7){ref-type="fig"}). In particular, we found an increase of *Fos* in *Htr2c*-expressing neurons ([Fig. 1a](#F1){ref-type="fig"}--[c](#F1){ref-type="fig"}), suggesting that LPBN^Htr2c^ neurons are capable of responding to high concentrations of sodium. We also measured *Fos* within neurons that express serotonin 1B receptor (*Htr1b*) or forkhead box protein 2 (*Foxp2*) in the LPBN, which were implicated in the regulation of sodium balance. *Htr1b* is another major serotonergic receptor in the LPBN, but we found little difference in *Fos* expression in *Htr1b*-expressing neurons ([Fig. 1c](#F1){ref-type="fig"}, [d](#F1){ref-type="fig"}). We observed little change in *Fos* in *Foxp2*-positive neurons ([Fig. 1c](#F1){ref-type="fig"}, [e](#F1){ref-type="fig"}), consistent with a previous report illustrating that Foxp2 neurons in the LPBN are instead responsive to sodium depletion^[@R10]^. We next examined co-localisation between *Htr2c* and other genes that are expressed in the LPBN. We found little co-localisation between *Htr2c* and *Htr1b* (2.1 ± 0.5 %) ([Fig. 1f](#F1){ref-type="fig"}, [g](#F1){ref-type="fig"}) and a small amount of co-localisation between *Htr2c* and *Foxp2* (10.7 ± 1.9 %) ([Fig. 1f](#F1){ref-type="fig"}, [h](#F1){ref-type="fig"}). Since oxytocin receptor (Oxtr)-expressing LPBN neurons were reported to regulate fluid intake^[@R17]^, we measured their co-localisation with *Htr2c* and found that 2.5 ± 0.3 % of LPBN^Htr2c^ neurons co-express *Oxtr* ([Fig. 1f](#F1){ref-type="fig"}, [i](#F1){ref-type="fig"}). Together, these results suggest that LPBN^Htr2c^ neurons are largely distinct from Htr1b neurons, sodium appetite-promoting Foxp2 neurons and fluid intake-regulating Oxtr neurons.

Since hypertonic saline may cause general visceral aversion as well as a sodium-aversive state, thus complicating the interpretation of these results, we next sought to investigate whether LPBN^Htr2c^ neurons are inhibited during sodium depletion. To target LPBN^Htr2c^ neurons, we generated an Htr2c-2A-iCre mouse line in which the expression of the codon-improved Cre recombinase (iCre) is under control of the endogenous regulatory sequences of *Htr2c* gene ([Extended Data Fig. 2a](#F8){ref-type="fig"}). The coding sequences of *Htr2c* and *iCre* were linked by a viral peptide bridge 2A sequence so that the two heterologous genes are initially transcribed from a single open reading frame and later segregated via a ribosomal-skip mechanism^[@R18]^. PCR genotyping detected both the targeted *Htr2c-2A-iCre* and the wild-type *Htr2c* alleles in female heterozygous Htr2c-2A-iCre mice ([Extended Data Fig. 2b](#F8){ref-type="fig"}). Since *Htr2c* is located on the X chromosome, we observed only one band (targeted) in the male hemizygous Htr2c-2A-iCre mice. Immunohistochemical analysis of Htr2c-2A-iCre activity using a tdTomato reporter revealed the expression of Htr2c in the choroid plexus, a brain region that is known to express high levels of Htr2c ([Extended Data Fig. 2c](#F8){ref-type="fig"}). To then test whether LPBN^Htr2c^ neuronal activity is modulated by sodium depletion, we targeted LPBN^Htr2c^ neurons using Htr2c-2A-iCre::tdTomato mice. Cell-attached recordings were taken from targeted LPBN^Htr2c^ neurons from mice maintained 7--8 days either on a control diet (0.11 % sodium) or a sodium-deficient diet. These diets differed only in sodium content and were otherwise identical in composition. Cells recorded from sodium-depleted mice showed a significant reduction in firing frequency compared to mice that were maintained on a control diet ([Fig. 1j](#F1){ref-type="fig"}, [k](#F1){ref-type="fig"}), suggesting that LPBN^Htr2c^ neurons are inhibited during sodium depletion. We also recapitulated these results from Htr2c-2A-iCre mice injected with AAV-DIO-EYFP into the LPBN ([Extended Data Fig. 3a](#F9){ref-type="fig"}--[c](#F9){ref-type="fig"}) to control for any possible transient Cre expression during development. We obtained similar results with LPBN^Htr2c^ neurons from mice that were depleted of sodium through subcutaneous injections of furosemide (50 mg/kg) and given access to water and sodium-deficient diet for 1 day ([Fig. 1l](#F1){ref-type="fig"}, [m](#F1){ref-type="fig"}). Taken together, these results suggest that LPBN^Htr2c^ neurons are responsive to changes in bodily sodium content.

Stimulation of LPBN^Htr2c^ neurons reduces sodium intake {#S4}
--------------------------------------------------------

To test the functional relevance of LPBN^Htr2c^ neurons in regulating sodium intake, we established a sodium depletion protocol to promote sodium appetite in mice ([Fig. 2a](#F2){ref-type="fig"}). We unilaterally injected AAV-DIO-hM3Dq-mCherry into the LPBN of Htr2c-2A-iCre mice (LPBN^Htr2c-hM3Dq^ mice) to specifically activate LPBN^Htr2c^ neurons ([Fig. 2b](#F2){ref-type="fig"}). We verified these constructs through current-clamp recordings. Applications of CNO (5 μM) could depolarise membrane potential (5.2 ± 1.7 mV in 3/3 cells tested) and induce robust action potentials ([Fig. 2c](#F2){ref-type="fig"}). We tested sodium-depleted LPBN^Htr2c-hM3Dq^ mice in a two-bottle assay, giving them a choice between distilled water and a solution containing 300 mM NaCl. In this condition, we found that CNO (1 mg/kg)-injected LPBN^Htr2c-hM3Dq^ mice showed a decrease in intake of 300 mM NaCl solution compared to saline-injected controls, while leaving water intake unchanged ([Fig. 2d](#F2){ref-type="fig"}). We confirmed that CNO injections caused no differences in water intake or 300 mM NaCl intake in AAV-DIO-mCherry-injected Htr2c-2A-iCre mice that were deprived of sodium, validating that CNO injections alone do not alter sodium intake ([Extended Data Fig. 4a](#F10){ref-type="fig"}, [b](#F10){ref-type="fig"}).

Since chemogenetics offers limited temporal resolution, we tested whether optogenetic activation of LPBN^Htr2c^ neurons in a temporally specific manner could recapitulate the chemogenetic results. To this end, we unilaterally injected AAV-DIO-hChR2 (E123T/T159C)-EYFP (hereafter 'ChETA~TC~-EYFP') into the LPBN of Htr2c-2A-iCre mice that were deprived of sodium ([Fig. 2e](#F2){ref-type="fig"}). Photostimulation of ChETA~TC~-EYFP-expressing neurons (20 Hz, 10 ms pulses, 1 s duration) generated inward currents in voltage-clamp mode and action potentials in current-clamp mode (5/5 cells tested) ([Fig. 2f](#F2){ref-type="fig"}). We then designed a closed-loop optogenetic protocol using a lickometer to deliver photostimulation (10 Hz, 10 ms pulses, 1 s duration) upon each lick. We tested AAV-DIO-ChETA~TC~-EYFP-injected mice in a one-bottle assay (300 mM NaCl) and found that photostimulation locked to each lick could acutely and potently suppress sodium intake whereas photostimulation had no effect in AAV-DIO-EYFP-injected control mice ([Fig. 2g](#F2){ref-type="fig"}, [h](#F2){ref-type="fig"}). Taken together, these results suggest that activation of LPBN^Htr2c^ neurons can rapidly suppress sodium intake during sodium depletion.

Inhibition of LPBN^Htr2c^ neurons promotes sodium intake {#S5}
--------------------------------------------------------

Having shown that activation of LPBN^Htr2c^ neurons significantly suppressed sodium intake, we next asked whether inhibiting the activity of these neurons could promote sodium intake. To this end, we injected AAV-DIO-hM4Di-mCherry bilaterally into the LPBN of Htr2c-2A-iCre mice (LPBN^Htr2c-hM4Di^ mice) ([Fig. 3a](#F3){ref-type="fig"}). We validated this chemogenetic construct *in situ* through current-clamp recordings. Applications of CNO (5 μM) indeed hyperpolarised membrane potential (−5.8 ± 0.6 mV in 11/13 cells tested) and silenced LPBN^Htr2c^ neurons ([Fig. 3b](#F3){ref-type="fig"}). CNO-injected LPBN^Htr2c-hM4Di^ mice showed an increase in consumption of 300 mM NaCl solution in the two-bottle assay during sodium depletion, while leaving water intake unchanged ([Fig. 3c](#F3){ref-type="fig"}). These data suggest that inhibition of LPBN^Htr2c^ neuronal activity can further accentuate sodium intake during sodium depletion.

To test whether inhibition of LPBN^Htr2c^ neuronal activity could drive sodium intake in a condition where sodium appetite is not as pronounced, we dehydrated LPBN^Htr2c-hM4Di^ mice ([Fig. 3d](#F3){ref-type="fig"}) before testing them on the two-bottle assay. Again, CNO injections into LPBN^Htr2c-hM4Di^ mice during the dehydrated state increased sodium intake compared to saline-injected controls, whereas water intake did not change ([Fig. 3e](#F3){ref-type="fig"}). Because both sodium depletion and dehydration result in hypovolemia, we tested mice under euvolemic conditions to determine whether LPBN^Htr2c^ neurons are necessary for the suppression of sodium appetite in normal circumstances ([Fig. 3f](#F3){ref-type="fig"}). Interestingly, euvolemic CNO-injected LPBN^Htr2c-hM4Di^ mice showed increased 300 mM NaCl intake without changing water intake ([Fig. 3g](#F3){ref-type="fig"}). This increased salt intake was abolished when 300 mM KCl was used instead of NaCl ([Fig. 3h](#F3){ref-type="fig"}), but was restored when given 300 mM NaHCO~3~ ([Fig. 3i](#F3){ref-type="fig"}). These results demonstrate the specificity of these behaviours towards sodium. Since sodium intake is typically obtained through feeding instead of ingesting concentrated salt solutions, we tested whether inhibition of LPBN^Htr2c^ neuronal activity could also promote intake of food that contains sodium. We tested LPBN^Htr2c-hM4Di^ mice on a fast-refeeding protocol ([Fig. 3j](#F3){ref-type="fig"}) using either a control diet or a sodium-deficient diet. CNO-injected LPBN^Htr2c-hM4Di^ mice showed an increase in food intake compared to saline-injected controls when offered a control diet ([Fig. 3k](#F3){ref-type="fig"}). Remarkably, this apparently orexigenic effect was abolished when LPBN^Htr2c-hM4Di^ mice were instead offered a sodium-deficient diet. These data suggest that the increase in food intake caused by inhibition of LPBN^Htr2c^ neuronal activity is contingent upon sodium being present in the diet. Finally, we confirmed that CNO injections caused no differences in food intake in AAV-DIO-mCherry-injected control mice on a fast-refeeding paradigm, indicating that CNO injections alone do not influence the intake of salt-containing food ([Extended Data Fig. 4a](#F10){ref-type="fig"}, [c](#F10){ref-type="fig"}).

Stimulation of LPBN^Htr2c^ neurons caused effects unrelated to sodium intake {#S6}
----------------------------------------------------------------------------

While inhibition of LPBN^Htr2c^ neuronal activity produced effects that were specific to sodium, LPBN^Htr2c-hM3Dq^ mice displayed effects that were independent of sodium. CNO-injected LPBN^Htr2c-hM3Dq^ mice showed both decreased 300 mM NaCl intake and water intake during dehydrated conditions, compared to saline-injected controls ([Extended Data Fig. 5a](#F11){ref-type="fig"}, [b](#F11){ref-type="fig"}). These data suggest that while LPBN^Htr2c^ neurons can decrease sodium intake during dehydration, LPBN^Htr2c^ neurons or a subset of them are also capable of reducing water intake under certain circumstances. We also found that activation of LPBN^Htr2c^ neurons caused sodium-independent decreases in food intake ([Extended Data Fig. 5a](#F11){ref-type="fig"}, [c](#F11){ref-type="fig"}). We speculated that these results may have been mediated by activation of calcitonin gene-related peptide (CGRP) neurons (LPBN^CGRP^ neurons), which were shown to reduce water intake during dehydration^[@R17]^ and to exert anorexigenic effects^[@R19]^. Indeed, we found that a subset (34 ± 3 %) of LPBN^CGRP^ neurons overlap with LPBN^Htr2c^ neurons ([Extended Data Fig. 6a](#F12){ref-type="fig"}, [b](#F12){ref-type="fig"}). However, it is unlikely that LPBN^CGRP^ neurons were responsible for mediating natriorexigenic effects since inhibition of these neurons reduced malaise^[@R19],[@R20]^ or increased meal size^[@R21]^, which would cause sodium-independent increases in ingestion. Furthermore, activation of LPBN^CGRP^ neurons did not decrease 300 mM NaCl intake during dehydration^[@R17]^. Notably during our optogenetic experiments, we used a photostimulation frequency of 10 Hz to avoid inducing malaise through LPBN^CGRP^ neurons since they have been shown to induce little malaise at 20 Hz^[@R19]^.

Glutamatergic projections from LPBN^Htr2c^ neurons to the central amygdala suppress sodium appetite {#S7}
---------------------------------------------------------------------------------------------------

To reveal the downstream circuitry of LPBN^Htr2c^ neurons, we made injections of AAV-DIO-EYFP into the LPBN of Htr2c-2A-iCre mice ([Fig. 4a](#F4){ref-type="fig"} and [Extended Data Fig. 7a](#F13){ref-type="fig"}). Among the brain regions that have been implicated in regulating sodium appetite, we found dense projections to the bed nucleus of the stria terminalis (BNST), central amygdala (CeA), paraventricular hypothalamus (PVH), parvicellular part of the ventroposterior thalamus (VPPC) and the median preoptic nucleus (MnPO). We also noted projections towards the ventromedial hypothalamus (VMH) and insular cortex (IC), but excluded these areas from further analysis since the VMH has little relevance to sodium appetite and the IC received sparse projections. To identify a candidate site for *in vivo* terminal photostimulation, we first carried out channelrhodopsin-assisted circuit mapping (CRACM) to identify functional connectivity between LPBN^Htr2c^ neurons and downstream regions. We bilaterally injected AAV- DIO-hChR2 (H134R)-mCherry into the LPBN of Htr2c-2A-iCre mice ([Fig. 4b](#F4){ref-type="fig"} and [Extended Data Fig. 7b](#F13){ref-type="fig"}), and then performed whole-cell patch-clamp recordings at target sites to record photo-excitatory postsynaptic currents (pEPSCs) and photo-inhibitory postsynaptic currents (pIPSCs) in voltage-clamp modes at −60 mV and −10 mV, respectively. We failed to detect either pEPSCs or pIPSCs in the dorsal BNST (dBNST), ventral BNST (vBNST) and PVH ([Extended Data Fig 7b](#F13){ref-type="fig"}). Contrary to this, we detected pEPSCs to the VPPC (1/11 neurons recorded; 9 %), MnPO (1/9 neurons recorded; 11 %) and CeA (14/25 neurons recorded; 56%) ([Fig. 4b](#F4){ref-type="fig"} and [Extended Data Fig. 7b](#F13){ref-type="fig"}). We also detected pIPSCs in the CeA (3/24 neurons recorded; 13%) but speculate that these are not monosynaptic, due to the longer response latencies (17.7 ± 0.8 ms, n = 3). Application of kynurenic acid (1 mM) abolished pEPSCs in the CeA, but upon washout, pEPSCs were recovered (4/4 neurons recorded; 100%), suggesting that the pEPSCs were glutamatergic ([Fig. 4c](#F4){ref-type="fig"}). Given the abundant connectivity between LPBN^Htr2c^ neurons and the CeA, we targeted this projection for *in vivo* stimulation by unilaterally injecting AAV-DIO-hChR2 (H134R)-mCherry into the LPBN of Htr2c-2A-iCre mice and implanting optic fibres ipsilaterally over the CeA ([Fig. 4d](#F4){ref-type="fig"}, [e](#F4){ref-type="fig"}). By using a closed-loop optogenetic to deliver photostimulation (10 Hz, 10 ms pulses, 1 s duration) upon each lick, we found that activating the LPBN^Htr2c^→CeA projection was sufficient to suppress sodium appetite in sodium-depleted mice ([Fig. 4f](#F4){ref-type="fig"}, [g](#F4){ref-type="fig"}). Together, these results suggest that LPBN^Htr2c^ neurons are able to suppress sodium appetite via glutamatergic projections to the CeA.

Htr2c agonist directly inhibits LPBN^Htr2c^ neuronal activity via K~ATP~ channels {#S8}
---------------------------------------------------------------------------------

To investigate the function of Htr2c on LPBN neurons at the electrophysiological level, we made whole-cell patch-clamp recordings from tdTomato-expressing LPBN^Htr2c^ neurons. Application of mCPP (4 μM), an Htr2c agonist, led to hyperpolarisation in a subset (10/57 cells tested, 17.5 %) of LPBN^Htr2c^ neurons ([Fig. 5a](#F5){ref-type="fig"} and [Extended Data Fig. 8](#F14){ref-type="fig"}). This effect was accompanied by a decrease in input resistance with a reversal potential of −86.9 ± 4.6 mV (n=10), suggesting the involvement of putative K^+^ conductance ([Fig. 5b](#F5){ref-type="fig"}--[d](#F5){ref-type="fig"}). We hypothesised that this increase in K^+^ conductance may have been through ATP-sensitive K^+^ (K~ATP~) channels. To test this, we pre-treated neurons with tolbutamide, a K~ATP~ channel blocker, before application of mCPP. No hyperpolarisations in response to mCPP were observed in this condition ([Fig. 5e](#F5){ref-type="fig"}, [g](#F5){ref-type="fig"}) and input resistance was not affected by mCPP ([Fig. 5f](#F5){ref-type="fig"}, [g](#F5){ref-type="fig"}). These data suggest that K~ATP~ channels mediate the hyperpolarisation of LPBN neurons upon Htr2c activation. Notably, tolbutamide alone caused a depolarisation of membrane potential (5.2 ± 0.9 mV) and an increase of input resistance in the majority of cells tested (n=13/20) ([Fig. 5e](#F5){ref-type="fig"}--[g](#F5){ref-type="fig"}), suggesting that K~ATP~ channels may contribute to the resting membrane potential of LPBN^Htr2c^ neurons. Since mCPP may also have affinity for Htr1b, we pre-treated slices with SB216641 (200 nM), an Htr1b antagonist. The effects of mCPP persisted in this condition, suggesting that the hyperpolarisation is independent of Htr1b ([Extended Data Fig. 9a](#F15){ref-type="fig"}, [b](#F15){ref-type="fig"}). Pre-treatment of slices with synaptic blockers (0.5 μM TTX, 1 mM kynurenic acid, 50 μM picrotoxin) also did not change the effects of mCPP, suggesting that these effects were postsynaptic ([Extended Data Fig. 9c](#F15){ref-type="fig"}, [d](#F15){ref-type="fig"}). A previous report suggested that a subset of neurons within the PVH projecting to the LPBN is calorically responsive^[@R22]^. Thus, we tested whether a similar phenomenon could be observed in LPBN^Htr2c^ neurons. However, fasting mice for 18 hours did not change the amplitude or proportion of responses to mCPP. These data suggest that LPBN Htr2c responses are not influenced by changes in caloric state ([Extended Data Fig. 9e](#F15){ref-type="fig"}--[g](#F15){ref-type="fig"}).

Deletion of *Htr2c* in LPBN reduces sodium intake during hypovolemia {#S9}
--------------------------------------------------------------------

To test the physiological role of Htr2c in the LPBN in regulating sodium intake, we generated LPBN-specific KO mice by injecting AAV-CMV-Cre-GFP directly into the LPBN of Htr2c^flox/Y^ mice (LPBN^Htr2cKO^ mice) ([Fig. 6a](#F6){ref-type="fig"}). We confirmed successful deletion of *Htr2c* in the LPBN through fluorescent *in situ* hybridisation ([Fig. 6b](#F6){ref-type="fig"}, [c](#F6){ref-type="fig"}). Subjecting LPBN^Htr2cKO^ mice to two-bottle choice experiments revealed that AAV-CMV-Cre-GFP-injected mice had decreased intake of 300 mM NaCl solution in both the sodium-depleted state and the dehydrated state compared to AAV-CMV-GFP-injected controls ([Fig. 6d](#F6){ref-type="fig"}, [e](#F6){ref-type="fig"}). However, food intake was unaltered in LPBN^Htr2cKO^ mice regardless of the diet used ([Fig. 6f](#F6){ref-type="fig"}). Taken together, these results suggest that Htr2c can inhibit LPBN neurons and thus act to disinhibit sodium intake, but plays no physiological role in regulating caloric appetite.

We speculated that the discrepancy between results obtained from LPBN^Htr2cKO^ mice and direct activation of LPBN^Htr2c^ neurons was presumably due to the degree of activation that occurs on these neurons. Removal of *Htr2c* would only be expected to have noticeable effects in conditions where serotonin is present, whereas the effects of chemogenetic modulation are not contingent upon this. Thus, serotonin release onto these neurons presumably occurs during conditions of hypovolemia (i.e. by sodium depletion or dehydration) but not during fasting, which may account for the lack of effect on food intake in LPBN^Htr2cKO^ mice, in spite of the presence of sodium in the diet. We tested this hypothesis by comparing the intake of water and 300 mM NaCl solution in euvolemic mice. In this state, we observed no difference in these measures between LPBN^Htr2cKO^ mice and control mice ([Fig. 6g](#F6){ref-type="fig"}), suggesting that the effects of *Htr2c* deletion in the LPBN are dependent on the hypovolemic state.

Finally, to identify sources of serotonin onto LPBN^Htr2c^ neurons, we injected wild-type mice with retrobeads ([Extended Data Fig. 10a](#F16){ref-type="fig"}) and then counterstained upstream-labelled sites for serotonin (5-HT). Interestingly, we found co-localisation of 5-HT and retrobead-labelled cells in the dorsal raphe nucleus (DR) and the median raphe nucleus (MnR) ([Extended Data Fig. 10b](#F16){ref-type="fig"}), suggesting that these raphe nuclei may be capable of modulating the LPBN neurons through serotoninergic projections.

Discussion {#S10}
==========

Maintenance of sodium content and body fluid volume is essential for survival and growth. Depletion of sodium is sensed through hypovolemia, which results in both increased retention of sodium and increased ingestion of sodium, the latter being manifested as sodium appetite. However, previous studies have consistently seen a delay between the onset of hypovolemia and sodium appetite, leading to formulation of the "disinhibition hypothesis"^[@R23]^ which proposed the relief of sodium appetite from inhibitory mechanisms. Although past studies have shown inhibitory influences over sodium appetite, whether removal of any of those influences can drive increased sodium appetite during euvolemic conditions has remained contentious. Here, we describe a subpopulation of neurons in the LPBN that suppresses sodium appetite. Animals tend to avoid ingesting high concentrations of sodium under normal circumstances and our results suggest that LPBN^Htr2c^ neurons may be a central substrate that facilitates this suppression of sodium appetite. Furthermore, we show that inhibition of these neurons is indeed able to drive sodium appetite, independently of thirst, even during euvolemic conditions. Our results were not restricted to sodium solutions, but also extended to sodium-containing foods, suggesting that certain aspects of appetite regulation by the LPBN may be coupled to osmoregulation. This finding was somewhat surprising since LPBN lesion studies showed either no increase^[@R8]^ or reduced sodium appetite^[@R9]^, which further highlights the heterogeneity of the LPBN neurons and the need for genetic segregation of its subpopulations.

Recent studies provided evidence that synergy between aldosterone and angiotensin II signalling underlie the promotion of sodium appetite^[@R4]^. Our results suggest that disinhibition of sodium appetite from the influence of the LPBN^Htr2c^ neurons may also play an important complementary role. We note that synergy and disinhibition are not mutually exclusive mechanisms since the activity of LPBN^Htr2c^ neurons might also be modulated by aldosterone and angiotensin II signalling. Indeed, aldosterone-sensitive 11β-hydroxysteroid dehydrogenase type 2 (HSD2) neurons within the NTS (NTS^HSD2^ neurons), which are considered to be the neural substrate for aldosterone signalling, have been shown to project to the LPBN^[@R3],[@R4]^. However, we find it unlikely that these neurons mediate their effects by directly terminating on LPBN^Htr2c^ neurons, since NTS^HSD2^ neurons have been shown to be Phox2b-positive neurons^[@R24]^, which are selectively glutamatergic^[@R25]^. NTS^HSD2^ neurons project instead to Foxp2 neurons within the LPBN (LPBN^Foxp2^ neurons), putatively sodium appetite-promoting neurons^[@R3],[@R4]^, which we have found not to overlap significantly with LPBN^Htr2c^ neurons in the central LPBN. The presence of both sodium appetite promoting and suppressing neurons in the LPBN is of interest, raising the possibility that these subpopulations may even interact with each other.

We found that LPBN^Htr2c^ neurons were responsive to bodily sodium content; responding to high concentrations of gastrically-loaded sodium and scaling down their activity during sodium depletion. While it is likely that LPBN^Htr2c^ neurons receive baroreceptive information via the nucleus tractus solitarius (NTS)^[@R8]^, it is well known that PBN neurons, particularly those in the waist region, are responsive to tastants^[@R26],[@R27]^. Previous studies regarding the detection of salt tastants have shown that the detection of aversive concentrations of salt occur in an amiloride-insensitive, non-sodium specific manner^[@R28]^. This raises the possibility that LPBN^Htr2c^ neurons mediate aversion towards high concentrations of salt in general. However, we find this to be unlikely as we found that chemogenetic inhibition of LPBN^Htr2c^ neurons selectively increased intake of sodium salts, but not potassium salts. Our results suggest that animals are able to translate decreased activity of LPBN^Htr2c^ neurons into a sodium-specific behaviour, as opposed to a generalised intake of all salts. Nevertheless, the nature of the information conveyed by LPBN^Htr2c^ neurons appears to be sufficient to regulate sodium intake on a rapid timescale during sodium depletion, as seen in our optogenetic experiments.

Our experiments showed that these rapid effects appear to be mediated by projections to the CeA, which has been anatomically implicated in regulating sodium appetite^[@R29],[@R30]^. We also found that LPBN^Htr2c^ neurons project to the vBNST, which has been shown to be a functionally relevant target of the angiotensin II receptor 1a (AT1a)-expressing neurons within the subfornical organ (SFO) (SFO^AT1a^ neurons)^[@R2]^ and NTS^HSD2^ neurons^[@R4]^, which both promote sodium appetite. Although this raised the attractive possibility that LPBN^Htr2c^ neurons may reduce sodium appetite by sending inhibitory projections to vBNST neurons innervated by SFO^AT1a^ and NTS^HSD2^ neurons, we failed to detect pIPSCs from LPBN^Htr2c^ neurons to vBNST neurons. In addition, the absence of pEPSCs from LPBN^Htr2c^ neurons to vBNST neurons likely ruled out the possibility that LPBN^Htr2c^ neurons inhibit vBNST neurons via excitation of interneurons. While we cannot rule out the possibility that LPBN^Htr2c^ neurons may be able to influence the vBNST on a slower time scale via neuromodulators, this would not account for the rapid effects observed from our closed-loop optogenetic stimulation of LPBN^Htr2c^ neurons. Nevertheless, given the dense GABAergic projections between the CeA and vBNST^[@R31],[@R32]^, the signals from the SFO^AT1a^ and NTS^HSD2^ neurons possibly act antagonistically to those from LPBN^Htr2c^ neurons, at the downstream level between the CeA and vBNST. Identifying whether the SFO^AT1a^→vBNST or NTS^HSD2^→vBNST projections are able to promote sodium intake in spite of LPBN^Htr2c^ neuronal activation will also be informative regarding the hierarchy and interplay between these sodium appetite-regulating populations. Finally we noted a strong projection to the dBNST, which was recently implicated in conveying chemosensory signals related to sodium^[@R33]^. However, we failed to detect any functional connectivity between dBNST and LPBN^Htr2c^ neurons through CRACM.

Involvement of serotonin in regulating sodium appetite through actions at the LPBN has been known through previous studies^[@R13],[@R14]^. However, the exact electrophysiological manifestations and physiological relevance of these effects were not explored. We found that activation of Htr2c causes inhibition of LPBN^Htr2c^ neurons, suggesting that serotonergic signalling within LPBN may serve to inhibit LPBN^Htr2c^ neurons in a certain context. Because Htr2c is considered an excitatory receptor, which is linked to Gq proteins, this result was somewhat surprising. However, previous reports suggest that Htr2c is able to engage both Gi and Gq related responses, as measured by decreases in cAMP production and chloride currents, which were abolished by pertussis toxin (PTX) and anti-Go nucleotides, respectively^[@R34],[@R35]^. Furthermore, Gi signalling has been linked to activation of K~ATP~ channels in cardiac myocytes^[@R36]^.

The decrease in sodium appetite during hypovolemia, by conditionally knocking out *Htr2c* from the LPBN (LPBN^Htr2cKO^ mice), suggests that ECF volume may regulate serotonergic signalling in the LPBN, which in turn controls sodium intake by modulation of LPBN^Htr2c^ neuronal activity. We found serotonergic projections to LPBN from the DR and MnR, consistent with other reports^[@R37],[@R38]^. The MnR is of particular interest since electrical stimulation of MnR has been shown to increase blood pressure, which was attenuated in the presence of an inhibitor of tryptophan hydroxylase^[@R39]^. On the other hand, electrical stimulation of the DR was shown to bidirectionally modulate blood pressure in a serotonin-independent manner. Thus serotonergic cells in the MnR may possibly engage neural circuitry to defend against hypovolemia; an appropriate behavioural output being increased sodium intake. In this model, serotonin release from the MnR onto the LPBN signals hypovolemia, which would act to disinhibit sodium appetite by acting on LPBN^Htr2c^ neurons. Detailed understanding of how blood pressure as well as bodily sodium content regulate serotonergic signalling and LPBN^Htr2c^ neuronal activity may be key in the development of novel anti-hypertensive agents via suppression of sodium appetite.

Online Methods {#S11}
==============

Animals {#S12}
-------

Htr2c-2A-iCre mice were generated by conventional gene targeting in C57BL/6 embryonic stem cells. All resulting chimeras displaying germline transmission were bred to mice of C57BL/6 background. The F1 pups from male chimeras were screened for those carrying the *Htr2c*^*iCre*^ allele using PCR genotyping with the following primers CL-9631: 5'- TTTGTGGGAAGGCCTGTAAC-3'; CL-10057: 5'-GGAGTGGGGGACTT TCCTAC-3'; CL-R309: 5'- TCCCTCACATCCTCAGGTTC-3'. *Htr2c*^*flox/Y*^ mice have been described previously^[@R40]^. Htr2c-2A-iCre mice were crossed with tdTomato (Ai14) reporter mice, Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J, for patch-clamp recordings. Mice were housed at 22--24 °C with a 12 h light:12 h dark cycle on normal chow (Teklad, 2018S). Sodium deficient diet (Research Diets, D08070603) and control diet (Teklad, TD94045) were only given during experimental procedures. Food and water was provided *ad libitum* when experiments were not being conducted. 6- to 8-week-old male mice were used for surgery. Allocation of animals to control or experimental groups were randomised and counter balanced. The investigator was not blinded to group allocation. The investigator was not blinded to experimental or control groups during behavioural experiments. However, all behavioural experiments involved stereotaxic injections thus blinding the investigator to whether the mice passed or failed viral expression exclusion criteria. All procedures were conducted according to the Korean Advanced Institute of Science and Technology (KAIST) Guidelines for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee (Protocol No. KA2018--80).

Stereotaxic injections {#S13}
----------------------

Mice were anaesthetised under isoflurane and had their heads fixed in a stereotaxic frame. Lidocaine (2 % wt/vol) was applied topically for pre-emptive analgesia. The skull was drilled and a 33 g blunt NanoFil needle (World Precision Instruments, NF33BL-2) was lowered to the target region (LPBN: A-P 5.22 mm, M-L 1.3 mm, D-V 3.5 mm) towards the target nucleus. For chemogenetic experiments, 0.08--0.15 μl of either AAV5-hSyn-DIO-hM3q-mCherry virus (University of North Carolina Vector Core; 3.8×10^12^ molecules/μl), AAV2-hSyn-DIO-hM4Di-mCherry (University of North Carolina Vector Core; 3.7×10^12^ molecules/μl) or AAV2-hSyn-DIO-mCherry (University of North Carolina Vector Core; 5.6×10^12^ molecules/μl) was injected into the LPBN of Htr2c-2A-iCre mice using a Hamilton syringe at a rate of 0.2 μl/min. 7--10 minutes after injection of the virus, the needle was then removed slowly. For optogenetic experiments, 0.12--0.14 μl of AAV5-EF1a-DIO-hChR2 (E123T/T159C)-p2A-EYFP (University of North Carolina Vector Core; 5.1 ×10^12^ molecules/μl), AAV5-EF1a-DIO-EYFP (University of North Carolina Vector Core; 6.5×10^12^ molecules/μl), AAV2-EF1a-DIO-hChR2 (H134R)-p2A-mCherry virus (University of North Carolina Vector Core; 5.1×10^12^ molecules/μl) or AAV2-EF1a-DIO-mCherry virus (University of North Carolina Vector Core; 3.2×10^12^ molecules/μl), was injected unilaterally. Monofibre optic cannulas (200 μm diameter core; NA = 0.37;) were implanted at A-P 5.22 mm, M-L 1.3 mm, D-V 3.2 mm for LPBN soma photostimulation and A-P 1.22, M-L 2.5, D-V 4.1mm for CeA terminal photostimulation, with Super-Bond C&B (Sun Medical). For conditional Htr2c deletion experiments, AAV5-CMV-GFP (University of North Carolina Vector Core; 4.7 ×10^12^ molecules/μl) or AAV5-CMV-Cre-GFP (University of North Carolina Vector Core; 4.5 ×10^12^ molecules/μl) were injected into the LPBN of Htr2c^flox/Y^ mice. Mice were kept on a heating pad and watched closely until regaining movement. Mice were handled for 1 week before starting behavioural experiments. At least 3 weeks of recovery was given before starting behavioural experiments. For anterograde tracing experiments, 0.1--0.16 μl of AAV5-EF1a-DIO-EYFP (University of North Carolina Vector Core; 6.5×10^12^ molecules/μl) were injected into the LPBN of Htr2c-2A-iCre mice. Mice were sacrificed 3 weeks later. For retrograde tracing, 0.12--0.17 μl of red retrobeads (Lumafluor) were injected into the LPBN of Htr2c-2A-iCre mice. Mice were sacrificed 5 days later.

Immunohistochemistry {#S14}
--------------------

Mice were anaesthetised with isoflurane and transcardially perfused with saline, followed by 4 % paraformaldehyde (PFA) and had their brains extracted. Brains were fixed overnight in PFA at 4 °C. After fixation, brains cryo-protected in a 30 % sucrose solution at 4 °C for 1--2 days. Brains were then frozen in FSC Clear (Leica) and sliced using a cryotome (Leica, CM1850) at 30 μm thickness. Slices were incubated in a blocking solution (2 % goat serum, 0.3 % Triton-X, in 0.1 M PBS) for 1 hour at room temperature on a shaking plate. Slices were then incubated in primary antibodies, 1:1,000 rabbit anti-CGRP (Bachem, T4032) or 1:1,000 rabbit anti-serotonin (Immunostar, 20080) solution for 17 hours at 4 °C. Slices were then washed for 10 minutes, three times in PBS. Slices were then incubated in a secondary antibody solution for 1 hour. Secondary antibody, Goat anti-rabbit 647 (Molecular Probes, A21245) was used at 1:200 dilution. Slices were then washed for 10 minutes, three times in PBS. DAPI was added (1:10,000) during the second PBS washing. Slices were then mounted on a microscope glass and mounted with DAKO mounting media. Z stack images were acquired with a confocal microscope (Zeiss, LSM780) and maximum intensity Z projected through ImageJ (NIH) software.

Fluorescent *in situ* hybridisation {#S15}
-----------------------------------

Mice were anaesthetised with isoflurane and transcardially perfused with DEPC-PBS, followed by 4 % paraformaldehyde (PFA) and had their brains extracted. Brains were fixed overnight in PFA at 4 °C. After fixation, brains were cryo-protected in a 30 % sucrose solution at 4 °C for 1--2 days. Brains were then frozen in O.C.T compound (Tissue-Tek, 4583) and sliced using a cryotome (Leica, CM1850) at 14 μm thickness at the KAIST Bio-core center. Slices were stored in a cryoprotectant solution (500 ml 0.1 M phosphate buffer (pH 7.2), 300 ml ethylene glycol, 300 g sucrose, remaining volume filled with DW to a total of 1 L) at −20 °C until further processing. mRNA signals were hybridized using RNAscope, according to the manufacturer's instructions. Protease treatment was done for 15 minutes at 40 °C using the HybEZ Hybridization System. Mm-Htr1b (Ref 315861), Mm-Foxp2 (Ref 428791), Mm-Oxtr (Ref 412171), Mm-Fos-C2 (Ref 316921-C2) and Mm-Htr2c-C3 (Ref 401001-C3) were used to detect *Htr1b*, *Foxp2*, *Oxtr*, *Fos* and *Htr2c* mRNA respectively. For *Fos* experiments, wild-type mice were acclimatised to oral-gavages by intragastrically loading them with saline for 1 week (10 μl/g). On the day of the assay, normal saline (154 mM NaCl) or hypertonic (1.5 M NaCl) were gastrically loaded into animals at 10 μl/g. Animals were sacrificed 25 minutes later. For conditional knockout experiments, EGFP-C1 (Ref 400281) and a custom made Mm-Htr2c-01-C3 probe (Ref 503281) that recognizes base pairs 724--1241 of NM_008312.4 were used to visualise *GFP* and *Htr2c* mRNA respectively. Z stack images were acquired with a confocal microscope (Zeiss, LSM780) and maximum intensity Z projected through ImageJ (NIH) software.

Behavioural experiments {#S16}
-----------------------

For fast-refeeding experiments, mice were housed in single cages for at least 1 week before conducting assays. The day before the assay, mice body weights were measured, food was cleared and bedding was replaced. Stock CNO was dissolved in DPBS at 8.75 mM. Stock CNO was diluted in sterile saline and administered intraperitoneally at 1 mg/kg, whereas DPBS was administered by diluting in sterile saline at a ratio consistent with CNO injections. In the text, saline injections refer to DPBS diluted in sterile saline. Injections were given 18 hours after fasting, at 10:00 on the day of the assay. Food was then reintroduced (either normal chow, sodium deficient diet or control diet) and then food intake and body weight were measured at 1, 2, and 4 hours after i.p. injections.

For two-bottle assays, mice were housed in single cages equipped with 2 volumetric drinking tubes (MedAssociates), containing either distilled water or 300 mM NaCl for at least 1 week before conducting assays. For sodium depletion, furosemide was administered subcutaneously at 50 mg/kg at 19:30 on the day before the assay. After furosemide injections, chow diet was replaced with a sodium deficient diet (Research Diets, D08070603), bedding was replaced and 300 mM NaCl bottles were removed. At 18:45 on the day of the assay, mice were injected with either saline or CNO in a counter balanced randomized manner. Water and sodium deficient diet was then removed. Assays began at 19:30, upon the re-introduction of distilled water and 300 mM NaCl solutions.

For one-bottle assays, mice were acclimated to lickometer-installed cage before testing. Mice were trained to use the lickometer-connected sipper bottle by depriving them of water and introducing them into the lickometer-installed cage the next day. Training was considered successful when mice made at least 100 licks within 30 minutes. On the day before testing, sodium depletion was carried out using the same sodium depletion protocol for two bottle assays. On the day of testing, mice were first habituated in the testing cage for 15 minutes without food, water or 300 mM NaCl. A bottle containing 300mM NaCl was then introduced and the number of licks were measured for 20 minutes. Both no photostimulation and photostimulation conditions were conducted at the same time of day for each mouse. All one-bottle assays were conducted during the dark-cycle.

For dehydration, both distilled water and 300 mM NaCl bottles were removed at 23:30 on the day before the assay. At 18:45 on the day of the assay, mice were injected with either saline or CNO in a counter balanced randomized manner. Normal chow was removed and bedding was replaced. Assays began at 19:30, upon the re-introduction of distilled water and 300 mM NaCl solutions.

For euvolemic experiments, distilled water, 300 mM salt solution and normal chow were available *ad libitum* until saline/CNO injections, at 18:45 on the day of the assay. Distilled water, 300mM salt solution and normal chow were then removed and the bedding was replaced. Assays began at 19:30, upon the re-introduction of distilled water and 300 mM salt solutions. All chemogenetic experiments were done as paired comparisons, assays being repeated at least 4 days later, with the treatments switched (i.e. saline to CNO or CNO to saline). Flox experiments were conducted using littermates. The investigator was not blinded to experimental or control groups.

Photostimulation protocol {#S17}
-------------------------

Patch cords (1 m long, 200 mm core diameter; Doric Lenses) were connected from a rotary joint (Doric Lenses) to monofibre optic cannulae through zirconia sleeves (Doric Lenses). A custom-made lickometer (Arduino) was used to detect licks and drive photostimulation upon each lick (10 Hz, 10 ms pulse width, 1 s duration). Blue light was generated from a laser (473 nm; Laserglow) at an intensity of 8.2--11.3 mW as measured at the tip of the optic cannula. We estimated the light power at the LPBN to be around 9.2--12.67 mW/mm^2^ and at the CeA to be 14.4--21 mW/mm^2^ as calculated by an online light transmission calculator (<http://web.stanford.edu/group/dlab/cgi-bin/graph/chart.php>).

Histology {#S18}
---------

After the completion of behavioural experiments, mice were perfused with saline and 4% PFA. Brains were extracted and post-fixed for 24 hours at 4 °C in 4 % PFA. 50 μm sections were then made on a vibratome (Leica VT1200S) and mounted with Vectashield mounting medium with DAPI, Hard Set (Vector, H-1500). Mice were excluded from analysis if vector expression was absent, incomplete or outside the area of interest. For optogenetic experiments, optic fibre tip locations were also validated and excluded when off target.

Electrophysiology {#S19}
-----------------

Whole-cell patch-clamp recordings from Htr2c neurons were made from the LPBN of 3--6 week old male and female mice. Mice were anaesthetized with isoflurane and transcardially perfused with a cutting solution (220 mM sucrose, 26 mM NaHCO~3~, 2.5 mM KCl, 1 mM NaH~2~PO~4~, 5 mM MgCl~2~, 1 mM CaCl~2~, 10 mM glucose, pH 7.3--7.35). The mice were then decapitated, and the entire brain was removed and immediately submerged in ice cold, carbogen-saturated cutting solution. 300 μm coronal sections were cut from the LPBN with a Leica VT1200S Vibratome and then incubated in oxygenated storage solution (123 mM NaCl, 26 mM, NaHCO~3~, 2.8 mM KCl, 1.25 mM NaH~2~PO~4~, 1.2 mM, MgSO~4~, 2.5 mM CaCl~2~, 10 mM glucose pH 7.3--7.35) at 34 °C for at least 1 hour before recording. Slices were transferred to the recording chamber and allowed to equilibrate for 10 minutes before recording. Recordings were made in the presence of a recording solution (126 mM NaCl, 26 mM, NaHCO~3~, 2.8 mM KCl, 1.25 mM NaH~2~PO~4~, 1.2 mM, MgSO~4~, 2.5 mM CaCl~2~, 5 mM glucose pH 7.3--7.35). The pipette solution for current-clamp whole-cell recording was modified to include an intracellular dye (Alexa Fluor 488): 120 mM K-gluconate, 10 mM KCl, 10 mM HEPES, 5 mM EGTA, 1 mM CaCl~2~, 1 mM MgCl~2~, 2 mM MgATP (pH 7.29). Epifluorescence was briefly used to target fluorescent cells, at which time the light source was switched to infrared differential interference contrast imaging to obtain the whole-cell recording (Nikon Eclipse FN-S2N equipped with a fixed stage and a QImaging optiMOS sCMOS camera). Electrophysiological signals were recorded using an Axopatch 700B amplifier (Molecular Devices), low-pass filtered at 2--5 kHz, and analyzed offline on a PC with Clampfit (Molecular Devices). Recording electrodes had resistances of 2--6 MΩ when filled with the K-gluconate internal solutions. Input resistance was assessed by measuring voltage deflection at the end of the response to hyperpolarizing rectangular current pulse steps (500 ms, from −5 to −25 pA, −10 to −50 pA or −20 to −100 pA). Membrane potential values were not compensated to account for junction potential (−8 mV). Cell-attached recordings were either made from 4--6 week old Htr2c-2A-iCre::tdTomato mice, or from 7 week old Htr2c-2A-iCre mice injected with AAV-DIO-EYFP. Recordings were carried out by filling pipettes with recording solution and at a holding potential of 0 mV. Photostimulation was delivered through an Optopatcher (A-M Systems), connected to a laser source (473 nm, Laserglow), through a patch cord with an NA of 4.8. Light intensity at the end of the optic fibre was measured as 6--8.4 mW. CRACM experiments were conducted in voltage-clamp mode at −60 mV and −10 mV to detect excitatory and inhibitory postsynaptic currents respectively. 3 single light pulses (10 ms) were delivered 1 s apart by triggering a pulse generator through pClamp software.

Drugs {#S20}
-----

TTX, picrotoxin, kynurenic acid, SB216641 and mCPP were acquired from Tocris. Lidocaine, tolbutamide and CNO were acquired from Sigma. Stock solutions of tolbutamide were made by dissolution in EtOH. Stock solutions TTX, picrotoxin, kynurenic acid and SB216641 were made by dissolution in DW. Stock solutions of CNO and mCPP were made in DPBS (Sigma, D8537).

Statistics {#S21}
----------

All statistics were done using Prism 6.01 (GraphPad) software. For electrophysiology experiments, nonparametric statistical tests (two-tailed Wilcoxon signed rank test or Mann-Whitney test) or repeated measures ANOVA with a Greenhouse-Geisser correction was used. For electrophysiology experiments, n represents the final number of recorded cells. All chemogenetic experiments were analysed using two-way repeated measures ANOVA, matched by time and treatment. Optogenetic experiments were analysed using two-way repeated measures ANOVA matched by photostimulation conditions. For fluorescent *in situ* hybridisation, data was analysed using two-tailed Mann-Whitney test or two-way ANOVA. Htr2c^flox/Y^ experiments were analysed using two-way repeated measures ANOVA, matched across time. *Post hoc* comparisons were always done using the Bonferroni correction. We presented adjusted P values for *post hoc* comparisons in [supplementary table 1](#SD1){ref-type="supplementary-material"}. N represent the final number of validated healthy animals. Data distribution was assumed to be normal but this was not formally tested. Sample sizes were not predetermined, but were matched to similar literature^[@R19],[@R22].^

Reporting Summary {#S22}
-----------------

Further information on research design is available in the Nature Research Reporting Summary linked to this article.

Code availability {#S23}
-----------------

Custom code used in this study is accessible from the corresponding author upon request.

Extended Data {#S24}
=============

![LPBN neurons respond to hypertonic saline.\
Hypertonic saline-loaded mice show more *Fos* in the LPBN than saline-loaded controls. Two-tailed Mann-Whitney test, Saline N = 5 mice, Hypertonic saline N =5 mice. P = 0.0317. All data represented as mean ± s.e.m. \*P \< 0.05.](nihms-1546061-f0007){#F7}

![Generation of an Htr2c-2A-iCre mouse line.\
**(a)** Htr2c-2A-iCre knock-in mice in which the coding sequences of *Htr2c* and *iCre* are linked by a viral peptide bridge 2A sequence. **(b)** Detection of wildtype and targeted *Htr2c* alleles by PCR genotyping. Similar results were obtained with at least 3 independent replications. **(c)** Immunohistochemical analysis of Htr2c-2A-iCre activity using a tdTomato reporter. Note high levels of tdTomato expression in the choroid plexus (CP). CC = corpus callosum. Similar results were obtained with at least 3 mice. Scale bar = 100 μm.](nihms-1546061-f0008){#F8}

![EYFP-expressing LPBN^Htr2c^ neurons are inhibited during sodium depletion.\
**(a)** Cell-attached recordings taken from Htr2c-2A-iCre mice injected with AAV5-E1fa-DIO-EYFP. **(b)** Representative cell-attached recording of LPBN^Htr2c^ neurons after 7 days of control diet, or 7 days of sodium-deficient diet. **(c)** Firing frequency of LPBN^Htr2c^ neurons between control diet-fed mice (left) and sodium-deficient diet-fed mice (right). Two-tailed Mann-Whitney test. Control diet n = 21 cells, sodium-deficient diet n = 24 cells. Control diet 1.2 ± 0.3 Hz, Sodium-deficient diet 0.4 ± 0.2 Hz, P = 0.007. All data represented as mean ± s.e.m. \*\*P \< 0.01.](nihms-1546061-f0009){#F9}

![CNO injections in AAV-DIO-mCherry-injected controls do not affect food intake, water intake or 300 mM NaCl intake.\
**(a)** Htr2c-2A-iCre mice injected with AAV2-hSyn-DIO-mCherry showed no changes in food intake, body weight or 300 mM NaCl intake. **(b**) No changes in water intake or 300 mM NaCl intake during sodium depletion. N = 5 mice. Water intake during sodium depletion: Two-Way Repeated Measures ANOVA: time (F(4, 16) = 20.52, P \< 0.0001), treatment (F(1, 4) = 0.5421, P = 0.5024), interaction (F(4, 16) = 0.6448, P = 0.6385). 300 mM NaCl intake during sodium depletion: Two-Way Repeated Measures ANOVA: time (F(4,16) = 108.1, P \< 0.0001), treatment (F(1, 4) = 0.1128, P = 0.7538), interaction (F(4, 16) = 0.3142, P = 0.8643). **(c)** No changes in food intake or body weight when using a control diet. N = 5 mice. Control diet food intake: Two-Way Repeated Measures ANOVA: time (F(3,12) = 223.9, P \< 0.0001), treatment (F(1, 4) = 0.2222, P = 0.6619), interaction (F(3,12) = 2.689, P = 0.0924). All data represented as mean ± s.e.m.](nihms-1546061-f0010){#F10}

![LPBN^Htr2c^ neuron activation can cause non-sodium related effects.\
**(a)** Unilateral injection of AAV5-hSyn-DIO-hM3Dq into the LPBN of Htr2c-2A-iCre mice. **(b)** Activation of LPBN^Htr2c^ neurons decreased water and 300 mM NaCl intake during dehydration in a two-bottle choice assay. N =11. Water intake during dehydration: Two-Way Repeated Measures ANOVA: time (F(4,40) = 67.06, P \< 0.0001), treatment (F(1, 10) = 8.707, P = 0.0145), interaction (F(4, 40) = 6.329, P = 0.0005). Post hoc tests using the Bonferroni correction. 300 mM NaCl intake during dehydration: Two-Way Repeated Measures ANOVA: time (F(4,40) = 31.38, P \< 0.0001), treatment (F(1, 10) = 17.76 P = 0.0018), interaction (F(4, 40) = 14.06 P = 0.0001). **(c)** Activation of LPBN^Htr2c^ neurons decreased food during a fast refeeding regardless of sodium content. N = 11. Control diet food intake (left): Two-Way Repeated Measures ANOVA: time (F(3,30) = 111.0, P \< 0.0001), treatment (F(1, 10) = 51.2, P \< 0.0001), interaction (F(3, 30) = 32.00, P \< 0.0001). Sodium-deficient diet food intake (right): Two-Way Repeated Measures ANOVA: time (F(3,30) = 50.59, P \< 0.0001), treatment (F(1, 10) = 27.74, P = 0.0004), interaction (F(3, 30) = 18.81, P \< 0.0001). All *post hoc* tests using the Bonferroni correction. All data represented as mean ± s.e.m. \*\*\*\*P \< 0.0001.](nihms-1546061-f0011){#F11}

![LPBN^Htr2c^ neurons colocalise with CGRP.\
(**a**) Schematic of experiment. Unilateral injection of AAV5-EF1a-DIO -EYFP into the LPBN of Htr2c-2A-iCre mice to visualise LPBN^Htr2c^ neurons (left). Colocalisation of EYFP labelled LPBN^Htr2c^ neurons with CGRP (right). Cyan = EYFP, Magenta = CGRP, Blue = DAPI. Scale bar = 100 μm. (**b**) Estimation of colocalisation between LPBN^Htr2c^ neurons and CGRP neurons. 3 slices taken from each mice. N = 7 mice.](nihms-1546061-f0012){#F12}

![Downstream circuitry of LPBN^Htr2c^ neurons.\
**(a)** Axonal projections visualised by unilateral injection of AAV5-EF1a-DIO-EYFP into the LPBN of Htr2c-2A-iCre mice. aca = anterior commissure (anterior part), acp = anterior commissure (posterior part), dBNST = bed nucleus of the stria terminalis (lateral division), fr = fasciculus retroflexus, ml = medial lemniscus, MnPO = median preoptic nucleus, opt = optic tract, PVH = paraventricular nucleus of the hypothalamus, scp = superior cerebellar peduncle, SPF = subparafascicular thalamus, st = stria terminalis, vBNST = bed nucleus of the stria terminalis (ventral part), VPPC = ventral posterior thalamus (parvicellular part). Scale bar = 400 μm. N = 7 mice. (**b**) Schematic of experiment. Bilateral injection of AAV2-DIO-hChR2 (H134R)-p2A-mCherry into the LPBN of Htr2c-2A-iCre mice (left). Voltage-clamp recordings taken at downstream sites (traces on the right). Blue rectangles indicate times of photostimulation.](nihms-1546061-f0013){#F13}

![Illustration showing the approximate spatial distribution of mCPP-responsive neurons within the LPBN.\
C = central LPBN, D = dorsal LPBN, E = external LPBN, I = internal LPBN, KF = Kolliker's Fuse, V = ventral LPBN.](nihms-1546061-f0014){#F14}

![Hyperpolarisation of LPBN^Htr2c^ neurons is not dependent on Htr1b and is postsynaptic.\
**(a)** Representative current clamp recording of an LPBN^Htr2c^ neuron pre-treated with SB216641 (200 nM). Hyperpolarisation in response to mCPP persists in presence of SB216641. Arrows indicate time at which current steps were applied. **(b)** Voltage deflections in response to hyperpolarising currents from the same neuron, showing decreased input resistance in response to mCPP. Current steps in trace made in 10 pA increments from −50 pA to 0 pA. **(c)** Representative current clamp recording of an LPBN^Htr2c^ neuron pre-treated with TTX (500 nM), kynurenic acid (KA, 1 mM) and picrotoxin (PTX, 50 μM), showing hyperpolarisation in response to mCPP. Arrows indicate time at which current steps were applied. **(d)** Voltage deflections in response to hyperpolarising currents from the same neuron, showing decreased input resistance in response to mCPP. Current steps in trace made in 10 pA increments from −50 pA to 0 pA. **(e)** Representative current clamp recording of an LPBN^Htr2c^ neuron from a fasted mouse (18 hours), showing hyperpolarisation in response to mCPP. Arrows indicate time at which current steps were applied. **(f)** Voltage deflections in response to hyperpolarising currents from the same neuron, showing decreased input resistance in response to mCPP. Current steps in trace made in 10 pA increments from −50 pA to 0 pA. **(g)** Graph summarising change in membrane potential in response to mCPP under conditions tested. Neither pre-treatment with SB216641, Synaptic blockers nor recordings from fasted mice changed the magnitude of response to mCPP. mCPP n = 10 cells, SB216641 n = 5 cells, Synaptic block n = 3 cells, Fasted n = 8 cells. Data represented as mean ± s.e.m](nihms-1546061-f0015){#F15}

![Serotoninergic projections to the LPBN.\
**(a)** Schematic of experiment. Unilateral injection of Lumafluor retrobeads into the LPBN of wildtype mice to visualise upstream neurons. **(b)** Arrows indicate colocalised cells. Aq = aqueduct, DR = dorsal raphe. Scale bar = 200 μm. N = 6 mice (upper). MnR = median raphe. Scale bar = 100 μm. N = 6 mice (lower).](nihms-1546061-f0016){#F16}
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![LPBN^Htr2c^ neurons are regulated by bodily sodium content.\
(**a**) Colocalisation of *Fos* and *Htr2c* in the LPBN after gastric loading of saline. Low magnification picture (left), higher magnification of area inside white box (right). Scale bars, left = 200 μm, right = 50 μm. Dashed lines indicate ventral spinocerebellar tract. scp = superior cerebellar peduncle. (**b**) Colocalisation of *Fos* and *Htr2c* in the LPBN after gastric loading of hypertonic saline. Low magnification picture (left), higher magnification of area inside white box (right). Scale bars, left = 200 μm, right = 50 μm. (**c**) Quantification of *Fos* expressing neurons that co-express *Htr2c, Htr1b or Foxp2*. Data points represent average number of cells counted per slice for each animal. Saline N = 5 mice, Hypertonic saline N =5 mice. Two-Way ANOVA: treatment (F(2,24) = 22.72, P \< 0.0001), gene (F(1, 24) = 7.671, P = 0.0107), interaction (F(2, 24) = 5.949 P = 0.0080). All post hoc tests done using the Bonferroni correction, P = 0.000552. (**d**) Colocalisation of *Fos* with *Htr1b* in the LPBN after gastric loading of saline or hypertonic saline. Scale bar = 50 μm. (**e**) Colocalisation of *Fos* with *Foxp2* in the LPBN after gastric loading of saline or hypertonic saline. Scale bar = 50 μm. (**f**) Quantification of percentage of *Htr2c* neurons that coexpress *Htr1b, Foxp2* or *Oxtr*. Data points represent average percentages counted per slice for each animal. N = 10 mice. (**g**) Colocalisation of *Htr1b* with *Htr2c* in the LPBN. Low magnification picture (left), higher magnification of area inside white box (right). Scale bars, left = 200 μm, right = 50 μm. (**h**) Colocalisation of *Foxp2* with *Htr2c* in the LPBN. Low magnification picture (left), higher magnification of area inside white box (right). Scale bars, left = 200 μm, right = 50 μm. (**i**) Colocalisation of *Oxtr* with *Htr2c* in the LPBN. Low magnification picture (left), higher magnification of area inside white box (right). Scale bars, left = 200 μm, right = 50 μm. (**j**) Representative cell-attached recording of an LPBN^Htr2c^ neuron after 7--8 days of control diet (upper), or 7--8 days of sodium-deficient diet (lower). (**k**) Firing frequency of LPBN^Htr2c^ neurons between control diet-fed mice (left) and sodium-deficient diet-fed mice (right). Two-tailed Mann-Whitney test. Control diet n = 14 cells, sodium-deficient diet n = 13 cells. Control diet 1.2 ± 0.4 Hz, Sodium-deficient diet 0.1 ± 0.1 Hz. P = 0.008. (**l**) Representative cell-attached recording of an LPBN^Htr2c^ neuron after furosemide and control diet treatment (upper) or furosemide and sodium-deficient diet treatment (lower). (**m**) Firing frequency of LPBN^Htr2c^ neurons between control diet fed mice (left) and sodium-deficient diet fed mice (right). Two-tailed Mann-Whitney test. Furosemide + control diet n = 11 cells, furosmide + sodium-deficient diet n = 10 cells. Furosemide + control diet 2.0 ± 0.3 Hz, furosemide + sodium-deficient diet 0.6 ± 0.2 Hz. P = 0.0007. All data represented as mean ± s.e.m. \*\*P \< 0.01, \*\*\*P \< 0.001.](nihms-1546061-f0001){#F1}

![Activation of LPBN^Htr2c^ neurons suppresses sodium intake.\
(**a**) Schematic illustration showing schedule for sodium depletion. (**b**) Unilateral injection of AAV5-hSyn-DIO-hM3Dq-mCherry into the LPBN of Htr2c-2A-iCre mice (left). Representative image of injection site (right). Scale bar = 200 μm. (**c**) DREADDs validated through current-clamp recordings. (**d**) Water intake during sodium depletion: Two-Way Repeated Measures ANOVA: time (F(4,40) = 33.11, P \< 0.0001), treatment (F(1, 10) = 0.8369, P = 0.3818), interaction (F(4, 40) = 1.712, P = 0.1663). 300 mM NaCl intake during sodium depletion: Two-Way Repeated Measures ANOVA: time (F(4,40) = 68.77, P \< 0.0001), treatment (F(1, 10) = 10.57 P = 0.0089), interaction (F(4, 40) = 7.546, P = 0.0001) N =11. (**e**) Unilateral injection of AAV5-EF1a-DIO-ChETA~TC~-EYFP or AAV5-EF1a-DIO-EYFP into the LPBN of Htr2c-2A-iCre mice. (**f**) Photostimulation of ChETA~TC~-expressing neurons (20 Hz, 10 ms pulses, 1 s duration) efficiently drives photocurrents and action potentials in voltage-clamp (upper) and current-clamp (lower) recordings, respectively. (**g**) Closed-loop optogenetic photostimulation of LPBN^Htr2c^ neurons during a one-bottle assay (300 mM NaCl) after sodium depletion. Cumulative licks of 300 mM NaCl in AAV5-EF1a-DIO-EYFP-injected mice (left) and AAV5-EF1a-DIO-ChETA~TC~-EYFP-injected mice (right). EYFP N = 4 mice, ChETA~TC~-EYFP N = 4 mice. (**h**) Total licks measured in AAV5-EF1a-DIO-EYFP-injected mice and AAV5-EF1a-DIO-ChETA~TC~-EYFP-injected mice at the end of the experiment. Two-Way Repeated Measures ANOVA: photostimulation (F(1,6) = 14.26, P =0.0092), virus (F(1, 6) = 1.986, P = 0.2085), interaction (F(1, 6) = 27.37, P = 0.002). EYFP N = 4 mice, ChETA~TC~-EYFP N = 4 mice. All post hoc tests done using the Bonferroni correction. All data represented as mean ± s.e.m. \*\*P \< 0.01, \*\*\*\*P \< 0.0001.](nihms-1546061-f0002){#F2}

![Inhibition of LPBN^Htr2c^ neurons increases sodium intake.\
(**a**) Bilateral injection of AAV2-hSyn-DIO-hM4Di-mCherry into the LPBN of Htr2c-2A-iCre mice (left). Representative image of injection site (right). Scale bar = 200 μm. (**b**) DREADDs validated through current clamp recordings. (**c**) Water intake during sodium depletion: Two-Way Repeated Measures ANOVA: time (F(4,40) = 33.11, P \< 0.0001), treatment (F(1, 10) = 0.8369, P = 0.3818), interaction (F(4, 40) = 1.712, P = 0.1663). 300 mM NaCl intake during sodium depletion: Two-Way Repeated Measures ANOVA: time (F(4,40) = 68.77, P \< 0.0001), treatment (F(1, 10) = 10.57, P = 0.0089), interaction (F(4, 40) = 7.546, P = 0.0001). N =11. (**d**) Schematic illustration showing schedule for dehydration. (**e**) Water intake during dehydration: Two-Way Repeated Measures ANOVA: time (F(4,44) = 127.3, P \< 0.0001), treatment (F(1, 11) = 0.001088, P = 0.9743), interaction (F(4, 44) = 0.09926, P = 0.9821). 300 mM NaCl intake during dehydration: Two-Way Repeated Measures ANOVA: time (F(4,44) = 59.29, P \< 0.0001), treatment (F(1, 11) = 9.495, P = 0.0104), interaction (F(4, 44) = 8.926, P \< 0.0001). N = 12. (**f**) Schematic illustration showing schedule for euvolemia tests. (**g**) Water intake: Two-Way Repeated Measures ANOVA: time (F(4,28) = 29.26, P \< 0.0001), treatment (F(1, 7) = 4.019, P = 0.085), interaction (F(4, 28) = 1.334, P = 0.282). 300 mM NaCl intake: Two-Way Repeated Measures ANOVA: time (F(4,28) = 12.04, P \< 0.0001), treatment (F(1, 7) = 5.615, P = 0.0496), interaction (F(4, 28) = 4.625 P, \< 0.0054). N = 8. (**h**) Water intake: Two-Way Repeated Measures ANOVA: time (F(4,28) = 19.15, P \< 0.0001), treatment (F(1, 7) = 0.01671, P = 0.9008), interaction (F(4, 28) = 0.5804, P = 0.6793). 300 mM KCl intake: Two-Way Repeated Measures ANOVA: time (F(4,28) = 13.26, P \< 0.0001), treatment (F(1, 7) = 0.02963, P = 0.8682), interaction (F(4, 28) = 0.4732, P = 0.7550). N = 8. (**i**) Water intake: Two-Way Repeated Measures ANOVA: time (F(4,28) = 8.521, P \< 0.0001), treatment (F(1, 7) = 0.5266, P = 0.4916), interaction (F(4, 28) = 0.2829, P = 0.8866). 300 mM NaHCO~3~ intake: Two-Way Repeated Measures ANOVA: time (F(4,28) = 14.14, P \< 0.0001), treatment (F(1, 7) = 8.089, P = 0.0249), interaction (F(4, 28) = 6.304, P = 0.0010). N = 8. (**j**) Schematic illustration showing schedule for fast-refeeding. (**k**) Control diet food intake N = 8 (left): Two-Way Repeated Measures ANOVA: time (F(3,21) = 226.7, P \< 0.0001), treatment (F(1, 7) = 13.06, P = 0.0086), interaction (F(3, 21) = 4.987, P = 0.0091). Sodium-deficient diet food Intake N = 12 (right): Two-Way Repeated Measures ANOVA: time (F(3,33) = 216.2, P \< 0.0001), treatment (F(1, 11) = 0.7438, P = 0.4069), interaction (F(3, 33) = 0.4746, P = 0.7021. All *post hoc* tests done using the Bonferroni correction. All data represented as mean ± s.e.m. \*\*P \< 0.01, \*\*\*P \< 0.001, \*\*\*\*P \< 0.0001.](nihms-1546061-f0003){#F3}

![Stimulation of the LPBN^Htr2c^→CeA projection suppresses sodium intake.\
(**a**) Schematic of experiment. Unilateral injection of AAV5-EF1a-DIO-EYFP into the LPBN of Htr2c-2A-iCre mice to visualise axonal projections (left). CeA = central amygdala, LA = lateral amygdala, opt = optic tract, st = stria terminalis. Scale bar = 400 um (right). N = 7 mice. (**b**) Schematic of experiment. Bilateral injection of AAV2-EF1a-DIO-hChR2 (h134R)-mCherry into the LPBN of Htr2c-2A-iCre mice (left). Voltage-clamp recordings taken at the CeA (right). Blue rectangles indicate times of photostimulation. (**c**) Kynurenic acid (1 mM) application abolishes pEPSCs at the CeA. Blue rectangle indicates time of photostimulation. (**d**) Schematic of experiment. Unilateral injection of AAV2-EF1a-DIO-hChR2 (h134R)-mCherry into the LPBN of Htr2c-2A-iCre mice and implantation of an optic fibre ipsilaterally over the CeA. (**e**) Representative image of injection site (left), and representative image of fibre implantation site (right). Dashed lines indicate fibre placement. Scale bars = 200 μm. (**f**) Closed-loop optogenetic photostimulation of LPBN^Htr2c^ neurons during a one-bottle assay (300 mM NaCl) after sodium depletion. Cumulative licks of 300 mM NaCl in AAV2-EF1a-DIO-mCherry-injected mice (left) and AAV2-EF1a-DIO-hChR2 (h134R)-mCherry-injected mice (right). mCherry N = 4 mice, hChR2-mCherry N = 6 mice. (**g**) Total licks measured in AAV2-EF1a-DIO-mCherry-injected mice and AAV2-EF1a-DIO-hChR2 (h134R)-mCherry-injected mice at the end of the experiment. Two-Way Repeated Measures ANOVA: photostimulation (F(1,8) = 15.61, P =0.0042), virus (F(1, 8) = 0.7701, P = 0.4058), interaction (F(1, 8) = 17.97, P = 0.00028). mCherry N = 4 mice, hChR2 -mCherry N = 6 mice. All *post hoc* tests done using the Bonferroni correction. All data represented as mean ± s.e.m. \*P \< 0.05, \*\*\*P \< 0.001.](nihms-1546061-f0004){#F4}

![Htr2c inhibits LPBN neurons via K~ATP~ channels.\
(**a**) Representative current clamp recording of an LPBN^Htr2c^ neuron, showing hyperpolarisation in response to mCPP. Arrows indicate time at which current steps were applied. (**b**) Voltage deflections in response to hyperpolarising currents from the same neuron, showing decreased input resistance in response to mCPP. Current steps in trace made in 10 pA increments from −50 pA to 0 pA. (**c**) Averaged I-V plot across responsive neurons, showing decreased input resistance in response to mCPP. Reversal potential was calculated to be −86.9 ± 4.6 mV. n = 6 cells. (**d**) Change in resting membrane potential (RMP) and input resistance across mCPP responsive neurons, Two-tailed Wilcoxon signed rank test, P = 0.002. n = 10 cells. (**e**) Representative current-clamp recording of an LPBN^Htr2c^ neuron. Neurons depolarize in response to tolbutamide and no longer respond to mCPP. Arrows indicate time at which current steps were applied. (**f**) Voltage deflections in response to hyperpolarising currents from the same neuron, showing increased input resistance in response to tolbutamide but no change during mCPP application. Current steps in trace made in 10 pA increments from −50 pA to 0 pA. (**g**) Individual data points for resting membrane potential (left) and input resistance (right) before and during tolbutamide application in all recorded cells. Mean depolarisation resulting from tolbutamide alone was 3.5 ± 0.8 mV. RMP: Repeated measures ANOVA with a Greenhouse-Geisser correction (F(1.127, 21.41) = 19.059, P = 0.001). *Post hoc* tests using the Bonferroni correction. Input resistance: Repeated measures ANOVA with a Greenhouse-Geisser correction (F(1.376, 26.51) = 8.627, P = 0.0035). All *post hoc* tests using the Bonferroni correction. n = 20 cells. All data represented as mean ± s.e.m. \*P \< 0.05 \*\*P \< 0.01.](nihms-1546061-f0005){#F5}

![Htr2c in the LPBN is necessary to disinhibit sodium appetite during hypovolemia.\
(**a**) Schematic of experiment. Bilateral injections of either AAV5-CMV-GFP or AAV5-CMV-Cre-GFP into Htr2c^flox/Y^ mice (left). Representative image of injection site (right). Scale bar = 200 μm. (**b**) Representative images validating knockout of *Htr2c* through *in situ* hybridisation. Scale bar = 40 μm. (**c**) Quantification of *Htr2c* knockout. Two-tailed Mann-Whitney test, P =0.0095. CMV-GFP N = 6 mice. CMV-Cre-GFP N =4 mice. (**d**) Water intake during sodium depletion: Two-Way Repeated Measures ANOVA: time (F(4,60) = 39.08, P \< 0.0001), treatment (F(1, 15) = 2.092, P = 0.1686), interaction (F(4, 60) = 1.389, P = 0.2485). 300 mM NaCl intake during sodium depletion: Two-Way Repeated Measures ANOVA: time (F(4,60) = 101.3, P \< 0.0001), treatment (F(1, 15) = 4.521, P = 0.0505), interaction (F(4, 60) = 4.141, P = 0.005). CMV-GFP N = 9 mice, CMV-Cre-GFP N = 8 mice. (**e**) Water intake during dehydration: Two-Way Repeated Measures ANOVA: time (F(4,60) = 140.1, P \< 0.0001), treatment (F(1, 15) = 1.249, P = 0.2813), interaction (F(4, 60) = 1.024, P = 0.4021). 300 mM NaCl intake during dehydration: Two-Way Repeated Measures ANOVA: time (F(4,60) = 48.04, P \< 0.0001), treatment (F(1, 15) = 5.117, P = 0.039), interaction (F(4, 60) = 4.276, P = 0.0041). CMV-GFP N = 9 mice, CMV-Cre-GFP N = 8 mice. (**f**) Control diet food intake (left): Two-Way Repeated Measures ANOVA: time (F(3, 45) = 302.9, P \< 0.0001), treatment (F(1, 15) = 1.976, P = 0.1802), interaction (F(3, 45) = 1.405, P = 0.2538). Sodium-deficient diet food intake (right): Two-Way Repeated Measures ANOVA: time (F(3,45) = 465.2, P \< 0.0001), treatment (F(1, 15) = 0.1966, P = 0.6638), interaction (F(3, 45) = 0.5274, P = 0.6657). CMV-GFP N = 9 mice, CMV-Cre-GFP N = 8 mice. (**g**) Water intake during euvolemia: Two-Way Repeated Measures ANOVA: time (F(4,24) = 36.98, P \< 0.0001), treatment (F(1, 6) = 1.254, P = 0.3056), interaction (F(4, 24) = 0.573, P = 0.6848). 300 mM NaCl intake during euvolemia: Two-Way Repeated Measures ANOVA: time (F(4,24) = 25.79, P \< 0.0001), treatment (F(1, 6) = 0.9208, P = 0.3743), interaction (F(4, 24) = 0.5215, P = 0.7208). CMV-GFP N = 4 mice, CMV-Cre-GFP N = 4 mice. All *post hoc* tests done using the Bonferroni correction. All data represented as mean ± s.e.m. \*P \< 0.05, \*\*P \< 0.01.](nihms-1546061-f0006){#F6}
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